- Clinical Trials
- April 2024
- 300 Pages
Global
From €2415EUR$2,500USD£2,065GBP
- Report
- February 2022
- 220 Pages
Global
From €9177EUR$9,500USD£7,847GBP
- Report
- February 2018
- 11 Pages
Global
From €9660EUR$10,000USD£8,260GBP
- Drug Pipelines
- February 2018
- 11 Pages
Global
From €9660EUR$10,000USD£8,260GBP
The BMS 986231 market is a segment of the cardiovascular drugs industry. It is composed of pharmaceuticals and biologics used to treat a variety of cardiovascular conditions, such as hypertension, coronary artery disease, and congestive heart failure. These drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular events. They can also be used to improve the quality of life for those with existing cardiovascular conditions.
The BMS 986231 market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production and sale of generic versions of these drugs. Show Less Read more